Gene therapy and molecular immunology unite to give new life to cancer immunotherapy

被引：4

作者：

Ando, D ^{[1
]}

机构：

[1] Cell Genesys Inc, Foster City, CA 94404 USA

来源：

MOLECULAR THERAPY | 2002年 / 5卷 / 06期

关键词：

D O I：

10.1006/mthe.2002.0616

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：665 / 667

页数：3

共 23 条

[1] GM-CSF-based cellular vaccines: a review of the clinical experience [J].

Borrello, I ;

Pardoll, D .

CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (02) :185-193

[2]

Chen SH, 1996, CANCER RES, V56, P3758

[3] AMPHOTROPIC MURINE LEUKEMIA RETROVIRUS IS NOT AN ACUTE PATHOGEN FOR PRIMATES [J].

CORNETTA, K ;

MOEN, RC ;

CULVER, K ;

MORGAN, RA ;

MCLACHLIN, JR ;

STURM, S ;

SELEGUE, J ;

LONDON, W ;

BLAESE, RM ;

ANDERSON, WF .

HUMAN GENE THERAPY, 1990, 1 (01) :15-30

[4] VACCINATION WITH IRRADIATED TUMOR-CELLS ENGINEERED TO SECRETE MURINE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR STIMULATES POTENT, SPECIFIC, AND LONG-LASTING ANTITUMOR IMMUNITY [J].

DRANOFF, G ;

JAFFEE, E ;

LAZENBY, A ;

GOLUMBEK, P ;

LEVITSKY, H ;

BROSE, K ;

JACKSON, V ;

HAMADA, H ;

PARDOLL, D ;

MULLIGAN, RC .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) :3539-3543

[5]

FEARON ER, 1988, CANCER RES, V48, P2975

[6] INTERLEUKIN-2 PRODUCTION BY TUMOR-CELLS BYPASSES T-HELPER FUNCTION IN THE GENERATION OF AN ANTITUMOR RESPONSE [J].

FEARON, ER ;

PARDOLL, DM ;

ITAYA, T ;

GOLUMBEK, P ;

LEVITSKY, HI ;

SIMONS, JW ;

KARASUYAMA, H ;

VOGELSTEIN, B ;

FROST, P .

CELL, 1990, 60 (03) :397-403

[7]

Fuchs E J, 1996, Semin Immunol, V8, P271, DOI 10.1006/smim.1996.0035

[8] Induction of melanoma-associated antigen systemic immunity upon intratumoral delivery of interferon-γ retroviral vector in melanoma patients [J].

Fujii, S ;

Huang, S ;

Fong, TC ;

Ando, D ;

Burrows, F ;

Jolly, DJ ;

Nemunaitis, J ;

Hoon, DSB .

CANCER GENE THERAPY, 2000, 7 (09) :1220-1230

[9] RESULTS OF TREATMENT OF 255 PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA WHO RECEIVED HIGH-DOSE RECOMBINANT INTERLEUKIN-2 THERAPY [J].

FYFE, G ;

FISHER, RI ;

ROSENBERG, SA ;

SZNOL, M ;

PARKINSON, DR ;

LOUIE, AC .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (03) :688-696

[10]

Hersh EM, 1997, CLIN CANCER RES, V3, P2623

← 1 2 3 →